The basic principle in the Biocidal Products Regulation ((EU) No 528/2012 (BPR)) is that a biocidal product must be authorised before it can be made available on the market or used in the European Economic Area (EEA) and Switzerland. The active substance is evaluated and, provided the criteria are fulfilled, is then approved in a specified product-type. The data on this page is active substance/product-type centric. The database includes active substances in the Review Programme, active substances not in the Review Programme as well as substances in Annex I of the BPR.